atrophic scar. Scar conditions and fibrosis of skin
Conditions
Interventions
Intervention 1: Control group: Patients receive two cc of SVF as an injection in one session on one side of their face. Intervention 2: Intervention group: Patients receive a combination of one cc of
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Acne scar grade 2 to 3 skin
Exclusion criteria
Exclusion criteria: Age under 18 years Family history of bleeding or coagulant diseases Taking anticoagulants or steroids Blood hemoglobin less than 10 and platelet count less than 150 Existence of active skin or systemic infection Having a malignancy or a history of receiving chemotherapy Breastfeeding or pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scar size. Timepoint: before and 3 month after the intervention. Method of measurement: Visio face. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One week after treatment. Method of measurement: Questionnaire and visit.;Patient Satisfaction. Timepoint: Three month after treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed